Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest update is out from Wai Chun Bio-Technology Ltd. ( (HK:0660) ).
Wai Chun Bio-Technology Limited has announced a series of remedial actions following its annual results announcement. The company is actively recruiting a new chief financial officer and additional accounting staff to improve its financial reporting and audit processes, with an expected hiring completion date by June 2025. Additionally, the company is working on finalizing a timetable for interim and annual results by July 2025, and plans to commence audit preparations in June 2025. These steps aim to enhance the company’s financial management and reporting capabilities, potentially impacting its operational efficiency and stakeholder confidence.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a company based in the Cayman Islands and is listed on the Hong Kong Stock Exchange. The company operates in the bio-technology sector and, along with its subsidiaries, focuses on the development and commercialization of bio-technological products and services.
YTD Price Performance: 27.27%
Average Trading Volume: 111,240
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$14.4M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.
